Skip to main content
Article
T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model: T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to Ribavirin Therapy
PLoS ONE
  • Brian B. Gowen, Utah State University
  • Donald F. Smee, Utah State University
  • Jeffery O. Hall, Utah State University
  • M. Wong
  • K. Jung
  • K. W. Bailey
  • J. R. Stevens
  • Y. Furuta
  • John D. Morrey, Utah State University
Document Type
Article
Publisher
PLoS
Publication Date
1-1-2008
Citation Information
Gowen BB, Smee DF, Hall JO, Wong M, Jung K, Bailey KW, Stevens JR, YF, and Morrey JD. T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model: T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to Ribavirin Therapy. PLoS ONE 3(11):e3725, 2008.